Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Neurobiology of Aging
|
September 9, 2020
Profound regional spectral, connectivity, and network changes reflect visual deficits in posterior cortical atrophy: an EEG study
Casper T Briels, Jakoba J Eertink, Cornelis J Stam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies
Fanny Orlhac, Jakoba J Eertink, Anne-Ségolène Cottereau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2021
Not Yet Time to Abandon the Deauville Criteria in Diffuse Large B-Cell Lymphoma
Sally F Barrington, Jakoba J Eertink, Henrika C W de Vet, et al.
EJNMMI Research
|
September 11, 2022
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients
Jakoba J Eertink, Martijn W Heymans, Gerben J C Zwezerijnen, et al.
EJNMMI Research
|
July 29, 2022
Combatting the effect of image reconstruction settings on lymphoma [<sup>18</sup>F]FDG PET metabolic tumor volume assessment using various segmentation methods
Maria C Ferrández, Jakoba J Eertink, Sandeep S V Golla, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 18, 2025
Can we obtain prognostic information from healthy tissue uptake and volume in baseline <sup>18</sup>F-FDG PET/CT imaging in diffuse large B-cell lymphoma?
Nienke R Gerards, Sanne E Wiegers, Anne L Bes, et al.
Frontiers in Medicine
|
May 31, 2024
The development process of 'fit-for-purpose' imaging biomarkers to characterize the tumor microenvironment
Jakoba J Eertink, Idris Bahce, John C Waterton, et al.
Blood Advances
|
September 18, 2023
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
Julia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2021
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
Jakoba J Eertink, Elisabeth A G Pfaehler, Sanne E Wiegers, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 27, 2022
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
Gerben J C Zwezerijnen, Jakoba J Eertink, Maria C Ferrández, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Neurobiology of Aging
|
September 9, 2020
Profound regional spectral, connectivity, and network changes reflect visual deficits in posterior cortical atrophy: an EEG study
Casper T Briels, Jakoba J Eertink, Cornelis J Stam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies
Fanny Orlhac, Jakoba J Eertink, Anne-Ségolène Cottereau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2021
Not Yet Time to Abandon the Deauville Criteria in Diffuse Large B-Cell Lymphoma
Sally F Barrington, Jakoba J Eertink, Henrika C W de Vet, et al.
EJNMMI Research
|
September 11, 2022
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients
Jakoba J Eertink, Martijn W Heymans, Gerben J C Zwezerijnen, et al.
EJNMMI Research
|
July 29, 2022
Combatting the effect of image reconstruction settings on lymphoma [<sup>18</sup>F]FDG PET metabolic tumor volume assessment using various segmentation methods
Maria C Ferrández, Jakoba J Eertink, Sandeep S V Golla, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 18, 2025
Can we obtain prognostic information from healthy tissue uptake and volume in baseline <sup>18</sup>F-FDG PET/CT imaging in diffuse large B-cell lymphoma?
Nienke R Gerards, Sanne E Wiegers, Anne L Bes, et al.
Frontiers in Medicine
|
May 31, 2024
The development process of 'fit-for-purpose' imaging biomarkers to characterize the tumor microenvironment
Jakoba J Eertink, Idris Bahce, John C Waterton, et al.
Blood Advances
|
September 18, 2023
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
Julia Driessen, Gerben J C Zwezerijnen, Heiko Schöder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2021
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
Jakoba J Eertink, Elisabeth A G Pfaehler, Sanne E Wiegers, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 27, 2022
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
Gerben J C Zwezerijnen, Jakoba J Eertink, Maria C Ferrández, et al.
Page
of 3